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Although cases of Mediterranean spotted fever (MSF) have been reported for decades in southeastern Romania, there are few
published data. We retrospectively studied 339 patients, diagnosed with MSF at the National Institute of Infectious Diseases “Prof.
Dr. Matei Bals” between 2000 and 2011, in order to raise awareness about MSF in certain regions of Romania. According to the
Raoult diagnostic criteria 171 (50.4%) had a score >25 points. Mean age was 52.5 years. One hundred and fifty-five (90.6%) patients
were from Bucharest and the surrounding region. Almost all patients presented with fever (99.4%) and rash (98.2%), and 57.9%
had evidence of a tick bite. There were no recorded deaths. Serologic diagnosis was made by indirect immunofluorescence assay.
Of the 171 patients, serology results for R. conorii were available in 147. One hundred and twenty-three (83.7%) of them had a titer
IgG ≥1 : 160 or a fourfold increase in titer in paired samples. MSF is endemic in southeastern Romania and should be considered in
patients with fever and rash even in the absence of recognized tick exposure. Since the disease is prevalent in areas highly frequented
by tourists, travel-associated MSF should be suspected in patients with characteristic symptoms returning from the endemic area.
1. Introduction
Mediterranean spotted fever (MSF) also called boutonneuse
fever is a tick-borne disease caused by Rickettsia conorii and
transmitted to humans by the brown dog tick, Rhipicephalus
sanguineus. MSF is traditionally considered to be endemic
to the regions bordering the Mediterranean basin including
southern Europe and northern Africa. Among the European
countries with relatively high R. conorii infection rates are
Portugal, Spain, France, and Italy [1–4]; however, the disease
is also present in central and eastern Europe, central and
southern Africa, and India [3]. It has also been reported in
travellers to endemic regions returning to their native coun-
tries [5].
R. conorii infection has been described by most countries
from the Balkan region.MSF cases have been reported in Bul-
garia, Croatia, continental Greece, and the province ofThrace
in Turkey [6–9], while serological evidence of infection was
found in patients without MSF from Serbia [10] and ticks
from Albania [11].
Cases of MSF have been reported in Romania since 1910,
with the first described outbreak occurring in 1948 in the
Bucharest area and in Dobrogea [12]. During the following
years the incidence decreased, and after 1959, 1-2 cases per
year were reported. Since 1988 small-sized outbreaks were
described usually limited to members of the same family or
community [13]. Since 2000, the National Institute of Public
Health conducted a systematic surveillance of MSF [13]. MSF
is endemic in southeastern Romania, with an overall inci-
dence in 2009 of 0.7 per 100,000 population [14]. However,
in some regions the incidence is much higher reaching 20
per 100,000 population per year. The majority of reported
cases occur in 2 regions, Bucharest and the surrounding area
and Dobrogea. A steady decrease in MSF incidence has been
recorded during the last decade in Romania. A serological
survey conducted in the MSF endemic area of southeastern
Romania in 2009 detected high R. conorii IgG seroprevalence
rates. The highest prevalence was recorded in Constanta
county where specific antibodies were detected in almost a
third of the individuals tested, followed by the Tulcea county
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and Bucharest with seropositivity frequency of 21.1% and
18.2%, respectively [15].
The objective was to raise awareness aboutMSF in certain
regions of Romania, which is not a Mediterranean country,
and to describe clinical and epidemiological characteristics
in this area.
2. Methods
2.1. Patient Population. Retrospective study of patients aged
over 14 years, reported as havingMSF according to epidemio-
logical, clinical, and laboratory characteristics by theNational
Institute of InfectiousDiseases “Prof. Dr.Matei Bals” between
2000 and 2011 was conducted.The hospital is a referral center
for infectious diseases in Bucharest, where patients from half
of the districts of Bucharest and six surrounding counties are
treated. Patient records were analysed, and data on epidemi-
ological, clinical, and laboratory features were collected.
According to the diagnostic criteria described by Raoult
et al., patients were further analysed if they had a diagnostic
criterion score of >25 (Table 1) [16].
2.2. Serological Diagnosis. Paired serum samples collected at
10–14 days interval and single serum samples were tested by
the indirect immunofluorescence assay method for anti-R.
conorii IgG antibody levels. Serum sample dilutions were 1/40
and 1/80, and examination of the slides wasmade on Eurostar
III Plus microscope at 400x magnification. The interpre-
tation of the test results was determined by the presence
of apple green fluorescence of cocobacilar morphology, the
fluorescence pattern being the positive and negative controls
provided by the kit producer (Rickettsia conorii IFA IgG
kit produced by Vircell, Spain). Each positive serum by the
screening test was analysed by twofold dilutions up to 1/640.
The highest serum dilution with visible fluorescence (positive
reaction) was considered the final titre of the serum.
Data were processed and analyzed by SPSS v17.0 (Statisti-
cal Package for the Social Sciences Inc, Chicago, IL, USA).
The study protocol was approved by the local ethics com-
mittee.
3. Results
Of 339 patients with reported MSF identified during the
study period, 171 (50.4%) had a diagnostic score >25 points
based on the Raoult criteria, and thus they were further
analyzed. The mean age of patients was 52.5 years with a
male to female sex ratio of 1 : 1.06. One hundred and fifty-five
(90.6%) patients were from Bucharest and the surrounding
region with the rest coming from other counties; 120 (70.2%)
patients lived in an urban area. The number of cases per year
ranged between 1 in 2006 and 42 in 2002 with 115 (67%) of
cases diagnosed between 2000 and 2005.
MSF cases were reported between May and November,
predominantly during late summer months. Most cases were
diagnosed in August (55, 32%) and July (40, 23%).
Almost all patients presented with fever 170/171 (99.4%)
and rash 168/171 (98.2%), but only 99/171 (57.9%) had evi-
dence of a tick bite. Patient characteristics according to the
Raoult et al. diagnosis criteria are shown in Table 1.
Table 1: Diagnostic criteria of Raoult et al. in the study patients.
Points
Patient
characteristics
N (%)
Patients
evaluated
Epidemiological criteria
Stay in endemic area 2 171 (100) 171
Occurrence between May and
September 2 165 (96.5) 171
Contact with dog ticks 2 114 (79.2) 144
Clinical criteria
Fever > 39∘C 5 170 (99.4) 171
Eschar 5 115 (67.3) 171
Maculopapular or purpuric
rash 5 168 (98.2) 171
Two of the three clinical
criteria 3 76 (44.4) 171
All three clinical criteria
present 5 95 (55.6) 171
Nonspecific laboratory findings
Platelets < 150,000/mm3 1 81 (50.9) 159
ALT or AST > 50 u/L 1 124 (78.5) 158
Serological criteria
Sole serum sample IgG ≥
1 : 160 10 92 (62.6) 147
Fourfold increase in paired
serum samples 20 31 (21.1) 147
Other common clinical symptoms encountered were
headache in 66/153 (43.1%), myalgias in 66/152 (43.4%),
arthralgias in 36/152 (23.7%), renal function impairment in
34/149 (22.8%), central nervous system symptoms in 7/149
(4.7%), and respiratory symptoms in 25/149 (16.8%) patients.
Amongpatientswith available laboratory tests, 54/170 (31.8%)
had a white blood cell count >10,000/mm3, 81/159 (50.9%)
had thrombocytopenia (platelet count < 150,000/mm3),
124/156 (79.5%) had an elevated erythrocyte sedimenta-
tion rate (>20mm/h), 76/138 (55.1%) had increased plasma
fibrinogen levels (>450mg/dL), and 124/158 (78.5%) had
elevated liver enzymes. Of the 171 patients, serology results
for R. conorii were available for 147 (86%), and 123 of them
(83.7%) had an IgG serum titer ≥1 : 160 or a fourfold increase.
All serum samples with a positive screening test result at 1/80
dilution also tested positive at 1/160 dilution. There were no
recorded deaths in our patient population.
4. Discussion
MSF is endemic in southeastern Romaniawith cases reported
ever since the beginning of the twentieth century and evi-
dence of past infection in up to a third of the tested individu-
als in some counties. The endemic area for MSF in Romania
comprises regions which are highly frequented by tourists:
Bucharest, the Danube Delta, and the coastal area bordering
the Black Sea. This study describes the epidemiological, clin-
ical, and laboratory characteristics of patients presenting to a
large infectious diseases hospital from Bucharest, Romania.
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In Romania, ticks and tick-borne diseases have been
documented ever since the end of the 19th century. Up to
now, 27 tick species are known to occur in Romania, 25
of them belonging to Ixodidae family (Dermacentor mar-
ginatus; Dermacentor reticulatus; Haemaphysalis concinna;
Haemaphysalis inermis; Haemaphysalis parva; Haemaphys-
alis punctata; Haemaphysalis sulcata; Hyalomma aegyp-
tium; Hyalomma detritum scupense; Hyalomma marginatum
marginatum; Ixodes apronophorus; Ixodes arboricola; Ixodes
crenulatus; Ixodes hexagonus; Ixodes laguri; Ixodes rediko-
rzevi; Ixodes ricinus; Ixodes rugicollis; Ixodes simplex; Ixodes
trianguliceps; Ixodes vespertilionis; Rhipicephalus annulatus;
Rhipicephalus bursa; Rhipicephalus rossicus; Rhipicephalus
sanguineus) and only two to Argasidae family (Argas persicus
and Argas reflexus) [17].
The studies show that in Romania, Rh. sanguineus begins
the questing activity in April and remains active throughout
the warm season until November [17]. The hosts for Rh. san-
guineus are the following: human; companion animals; live-
stock; rodents.
At the national level, the highest incidence (44 cases
per 100,000 population) was recorded in 2001 in Constanta
county, whereas in Bucharest the number of MSF cases
peaked in 2002 (3.15 cases per 100,000 population). After this
peak that occurred a decade ago, the incidence decreased in
all endemic areas of Romania [13]. A similar epidemiological
trend was recorded in neighbouring Bulgaria [6]. Other
authors described fluctuating trends of MSF incidence in
Spain, Italy, France, and Croatia [3, 7].
We also found in our study a decreasing trend in
the number of cases presenting at our hospital with more
than two-thirds of the cases diagnosed during the first
half of the study period. It should be noted that because
of reduced disease severity not requiring hospital admission
and the inability to perform serology in all suspected cases,
MSF might be underdiagnosed and underreported. Most
cases were identified during late spring and summer, which
is the period of greatest tick activity. The peak in the number
of cases in August might be attributed to the preponderant
involvement of immature tick stages in disease transmission
[18]. We found that the majority of patients diagnosed with
MSF were living in an urban area.
Since dogs are the main hosts for Rh. sanguineus, indi-
viduals with frequent contact with dogs are at increased risk
for developing the disease [19, 20]. We hypothesize that the
stray dogs in Bucharest might have contributed to a greater
likelihood of contact between humans and the vector.
The classical clinical picture of MSF is comprised of fever,
rash, and the presence of a black eschar. Fever and rash were
seen in almost all patients, and the eschar was also commonly
reported in over 67% of individuals. Although R. conorii is
the main cause of MSF in Europe, other rickettsial species
(such as R. monacensis, R. massiliae, and R. aeschlimannii)
have been shown to produce aMSF-like disease [21]; however,
data on other Rickettsia spp. that may cause a similar disease
in Romania are lacking. MSF mortality is generally low,
estimated at about 2.5% [18]. In our study none of the patients
died, but severe cases might have been underdiagnosed
because MSF may not have been considered as a diagnosis
in critical patients with rash or because serological tests may
have been negative if performed too early in the course of
the disease. According to the national MSF surveillance data
between 2000 and 2008, only 2 deaths were reported [13].
Other studies from the region also found low mortality rates
[6, 22]. Some R. conorii strains, however, have been reported
to cause higher mortality rates, over 32% in hospitalized
patients [1].
Althoughmost of the patients had serological evidence of
MSF, in some cases there was a delay of 7–15 days in antibody
detection after disease onset [18], which might explain an
initial negative serology. Another possible explanation for a
negative serology could be infection by another rickettsial
species causing MSF-like disease [21].
In order to improve surveillance of MSF, in 2012, the
National Institute of Public Health implemented a new
surveillance methodology. The case definition was based
on epidemiological criteria (tick bite or exposure, contact
with dogs, professional exposure, or recreational activities in
potentially tick-infested areas), clinical criteria (fever, myal-
gias, nonpruritic, or maculopapular rash predominantly
affecting limbs with/without the presence of a 2–5mm lesion
suggesting a tick bite), and laboratory criteria (increase in
specific IgM antibody levels in paired serum samples or four-
fold increase of specific IgG levels in paired serum samples).
A case of MSF was considered confirmed if epidemiolog-
ical, clinical, and laboratory criteria were present. Patients
are considered to have probable MSF if the clinical and
epidemiological criteria were present and suspected when
only the clinical criteria were fulfilled. The initiative of the
National Institute of Public Health to implement a specific
methodology might provide a more accurate picture of MSF
epidemiology in Romania and increase awareness of the
disease among general practitioners and therefore increased
MSF reporting.
The limitation of our study was the retrospective analysis,
which might have contributed to missing data. Furthermore,
PCR techniques may have been a more useful and sensitive
test to identify the R. conorii strain involved. We were also
unable to identify other rickettsial species causing MSF-like
disease in our patient population.
In conclusion MSF is endemic in southeastern Romania
and should be considered in patients presenting with fever
and rash even in the absence of recognized tick exposure.
Since the disease is prevalent in areas highly frequented by
tourists (Bucharest, theDanubeDelta, and the coastal region)
and there are increased chances of contact with stray dogs
in these areas, travel-associated MSF should be considered
in patients with characteristic symptoms returning from this
endemic area.
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